Vol 27 (2024): Continuous Publishing
Clinical vignette
Published online: 2024-06-18

open access

Page views 153
Article views/downloads 79
Get Citation

Connect on Social Media

Connect on Social Media

A case of Muir–Torre syndrome on [18F]FDG PET/CT

Thomas Fredericks1, Khaled Mohamed1, Minh X Nguyen1, Sindhu Kumar1, Savas Ozdemir1
Pubmed: 38887062
Nucl. Med. Rev 2024;27:13-16.


Muir–Torre syndrome (MTS) is a rare genetic disorder, considered a subtype of Lynch syndrome, that causes sebaceous cutaneous tumors and increases the risk of internal visceral tumors. We present a case of a 63-year-old male with a history of MTS with sebaceous tumors, colorectal, and urothelial cancers who underwent fluorine-18-deoxyglucose positron emission tomography/ computed tomography [18F]FDG PET/CT to follow-up on multiple [18F]FDG avid skin lesions and right pelvic lymph nodes. Although few reports are available detailing the utility of [18F]FDG PET/CT in this rare disease, this modality appears useful, and superior, to computed tomography in the diagnosis and follow-up of MTS.

Article available in PDF format

View PDF Download PDF file


  1. Bhaijee F, Brown AS. Muir-Torre syndrome. Arch Pathol Lab Med. 2014; 138(12): 1685–1689.
  2. Gamret AC, Klingbeil KD, Fertig RM, et al. Muir-Torre syndrome. Skinmed. 2020; 18(6): 382–384.
  3. John AM, Schwartz RA. Muir-Torre syndrome (MTS): an update and approach to diagnosis and management. J Am Acad Dermatol. 2016; 74(3): 558–566.
  4. Ishiguro Y, Homma S, Yoshida T, et al. Usefulness of PET/CT for early detection of internal malignancies in patients with Muir-Torre syndrome: report of two cases. Surg Case Rep. 2017; 3(1): 71.
  5. Bertagna F, Biaotto G, Bosio G, et al. F18-FDG-PET/CT in a patient affected by Lynch syndrome. Nucl Med Rev Cent East Eur. 2010; 13(2): 87–89.
  6. Kviatkovsky B, Landau E, Siddique M, et al. FDG-PET-positive lower-extremity sebaceous-gland carcinoma in a patient with Muir-Torre syndrome. Radiol Case Rep. 2016; 10(2): 1115.